Product
Neoantigen polypeptide vaccine
1 clinical trial
1 indication
Indication
Ovarian CancerClinical trial
Application of MRD Combined With Personalized Vaccine in the Adjuvant Treatment of Postoperative Recurrence Prevention of Epithelial Ovarian CancerStatus: Recruiting, Estimated PCD: 2026-12-31